Learn More
BACKGROUND The MInT study was the first to show improved 3-year outcomes with the addition of rituximab to a CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone)-like regimen in young(More)
BACKGROUND Chronic antigenic stimulation might have a role in the pathogenesis of monoclonal gammopathy of unknown significance (MGUS) and multiple myeloma. The aim of this study was to search for(More)
Hyperphosphorylated paratarg-7 (pP-7) is a frequent target of paraproteins in German patients with monoclonal gammopathy of undetermined significance (MGUS)/multiple myeloma (MM). The frequency of(More)
e18573 Background: Paratarg-7 (P-7) is a frequent target of paraproteins from patients with MGUS, multiple myeloma (MM) and Waldenstroem's macroglobulinemia (WM). Patients with paratarg-7 specific(More)
  • 1